• Syed Dawood Shah

• Syed Abdul Bari

• Hazrat Ali

• Muhammad Samsoor Zarak

• Sheikh Ahmed

• Mir Zaman Kasi

Abstract

Objectives: To compare the effectiveness of Results: In Group A, mean age was 52±1.27 pretreatment with beta blocker vs without beta years where as in Group B it was 54±1.32. In blocker in patients presenting with acute coronary Group A, 62% patients were male and 38% syndrome (ACS) in terms of early mortality. patients were female where as in Group B 60% Methodology: Atotal of 348 consecutive patients patients were male and 40% patients were presenting with ACS were included in the study. All female. In Group A, efficacy was in 90% patients with diabetes mellitus were excluded. All patients where as in Group B efficacy was in 82% patients were monitored in the CCU and patients. echocardiograms were performed. All were Conclusion: Pretreatment with beta blocker was examined and evaluated for third heart sound and more effective then treatment without beta blocker crepitations. Group A (Pretreatment group) was in patients presenting with acute coronary those who are taking beta blocker already for any syndrome in terms of early mortality. (Rawal Med J cause before presentation and Group B (control 201;43:217-219). group) was those who are not taking beta blocker Key words: Beta blocker, acute coronary syndrome, early mortality. before.

Previous Article 

Next Article